2008•Lung CancerRequires access
Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours
Pasi A. Jänne
Open publisher page 84 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.
Pasi A. Jänne
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 84 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Gefitinib, Erlotinib, T790M, Medicine, Lung cancer, Epidermal growth factor receptor, Resistance mutation, EGFR inhibitors